RESEARCH
Platelet-rich Plasma (PRP) Versus Corticosteroid Injection for Painful Shoulder Conditions: Powered by OE M.I.N.D. .
Shoulder pain is one of the most prevalent musculoskeletal complaints, and corticosteroid injections have long been a mainstay in its management. However, platelet-rich plasma (PRP) has emerged as a promising alternative, especially for chronic tendon-related conditions. Across six RCTs, corticosteroid injections consistently provided quicker relief, offering better short-term improvements in pain and function within the first 3–6 weeks. Beyond that early window, however, PRP began to show an advantage, with several trials reporting better mid-term outcomes—particularly between 3 and 6 months—while later follow-up periods showed little difference between the two options. Safety profiles were similar, with no notable increases in adverse events or conversions to surgery.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
